Commercial hybrid closed-loop systems available for a patient with type 1 diabetes in 2022

Technological advances offer the opportunity to improve glycemic control and reduce the risk of complications and burden of type 1 diabetes while improving patient quality of life. Closed-loop insulin delivery systems take the technology to a larger scale by integrating CGM systems with an insulin p...

Descripción completa

Detalles Bibliográficos
Autores principales: Seget, Sebastian, Tekielak, Anna, Rusak, Ewa, Jarosz-Chobot, Przemysława
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Review paper | Praca poglądowa
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226452/
https://www.ncbi.nlm.nih.gov/pubmed/37218723
http://dx.doi.org/10.5114/pedm.2023.126359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226452/
https://www.ncbi.nlm.nih.gov/pubmed/37218723
http://dx.doi.org/10.5114/pedm.2023.126359

Ejemplares similares